An enzyme-linked receptor mechanism for nitric oxide-activated guanylyl cyclase

被引:43
作者
Roy, Brijesh [1 ]
Halvey, Edward J. [1 ]
Garthwaite, John [1 ]
机构
[1] UCL, Wolfson Inst Biomed Res, London WC1E 6BT, England
基金
英国惠康基金; 英国医学研究理事会;
关键词
D O I
10.1074/jbc.M801712200
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Nitric oxide (NO) exerts physiological effects by activating specialized receptors that are coupled to guanylyl cyclase activity, resulting in cGMP synthesis from GTP. Despite its widespread importance as a signal transduction pathway, the way it operates is still understood only in descriptive terms. The present work aimed to elucidate a formal mechanism for NO receptor activation and its modulation by GTP, ATP, and allosteric agents, such as YC-1 and BAY 41-2272. The model comprised a module in which NO, the nucleotides, and allosteric agents bind and the protein undergoes a conformational change, dovetailing with a catalytic module where GTP is converted to cGMP and pyrophosphate. Experiments on NO-activated guanylyl cyclase purified from bovine lung allowed values for all of the binding and isomerization constants to be derived. The catalytic module was a modified version of one describing the kinetics of adenylyl cyclase. The resulting enzyme-linked receptor mechanism faithfully reproduces all of the main functional properties of NO-activated guanylyl cyclase reported to date and provides a thermodynamically sound interpretation of those properties. With appropriate modification, it also replicates activation by carbon monoxide and the remarkable enhancement of that activity brought about by the allosteric agents. In addition, the mechanism enhances understanding of the behavior of the receptor in a cellular setting.
引用
收藏
页码:18841 / 18851
页数:11
相关论文
共 77 条
[61]   Inhibition of deactivation of NO-sensitive guanylyl cyclase accounts for the sensitizing effect of YC-1 [J].
Russwurm, M ;
Mergia, E ;
Mullershausen, F ;
Koesling, D .
JOURNAL OF BIOLOGICAL CHEMISTRY, 2002, 277 (28) :24883-24888
[62]   Molecular mechanisms involved in the synergistic activation of soluble guanylyl cyclase by YC-1 and nitric oxide in endothelial cells [J].
Schmidt, K ;
Schrammel, A ;
Koesling, D ;
Mayer, B .
MOLECULAR PHARMACOLOGY, 2001, 59 (02) :220-224
[63]   Mechanisms of nitric oxide independent activation of soluble guanylyl cyclase [J].
Schmidt, P ;
Schramm, M ;
Schröder, H ;
Stasch, JP .
EUROPEAN JOURNAL OF PHARMACOLOGY, 2003, 468 (03) :167-174
[64]   NO-independent regulatory site on soluble guanylate cyclase [J].
Stasch, JP ;
Becker, EM ;
Alonso-Alija, C ;
Apeler, H ;
Dembowsky, K ;
Feurer, A ;
Gerzer, R ;
Minuth, T ;
Perzborn, E ;
Pleiss, U ;
Schröder, H ;
Schroeder, W ;
Stahl, E ;
Steinke, W ;
Straub, A ;
Schramm, M .
NATURE, 2001, 410 (6825) :212-215
[65]   Pharmacological actions of a novel NO-independent guanylyl cyclase stimulator, BAY 41-8543:: in vitro studies [J].
Stasch, JP ;
Alonso-Alija, C ;
Apeler, H ;
Dembowsky, K ;
Feurer, A ;
Minuth, T ;
Perzborn, E ;
Schramm, M ;
Straub, A .
BRITISH JOURNAL OF PHARMACOLOGY, 2002, 135 (02) :333-343
[66]   SOLUBLE GUANYLATE-CYCLASE FROM BOVINE LUNG - ACTIVATION WITH NITRIC-OXIDE AND CARBON-MONOXIDE AND SPECTRAL CHARACTERIZATION OF THE FERROUS AND FERRIC STATES [J].
STONE, JR ;
MARLETTA, MA .
BIOCHEMISTRY, 1994, 33 (18) :5636-5640
[67]   The ferrous heme of soluble guanylate cyclase: Formation of hexacoordinate complexes with carbon monoxide and nitrosomethane [J].
Stone, JR ;
Marletta, MA .
BIOCHEMISTRY, 1995, 34 (50) :16397-16403
[68]   Exchange of substrate and inhibitor specificities between adenylyl and guanylyl cyclases [J].
Sunahara, RK ;
Beuve, A ;
Tesmer, JJG ;
Sprang, SR ;
Garbers, DL ;
Gilman, AG .
JOURNAL OF BIOLOGICAL CHEMISTRY, 1998, 273 (26) :16332-16338
[69]   Organic phosphates as a new class of soluble guanylate cyclase inhibitors [J].
Suzuki, T ;
Suematsu, M ;
Makino, R .
FEBS LETTERS, 2001, 507 (01) :49-53
[70]   YC-1, a nitric oxide-independent activator of soluble guanylate cyclase, inhibits platelet-rich thrombosis in mice [J].
Teng, CM ;
Wu, CC ;
Ko, FN ;
Lee, FY ;
Kuo, SC .
EUROPEAN JOURNAL OF PHARMACOLOGY, 1997, 320 (2-3) :161-166